In a report released today, Andrew Lazar from Barclays maintained a Sell rating on Campbell Soup (CPB – Research Report), with a price target ...

Gaia posted double-digit year-over-year revenue growth, driven in part by an increase in the streaming video provider’s ...

OnKure's drug candidate pipeline is highlighted by OKI-219, a selective PI3K alpha H1047R inhibitor for the treatment of certain types of breast cancer that began clinical trials in February 2024.